12.7 million patients in Europe suffer
from heart valve disease!
Heart valve disease is one of the most serious heart complications, affecting more than 12.7 million patients in Europe.
Over the past decade, innovative minimally invasive catheter-based solutions have been developed for the treatment of aortic and mitral valve disease, creating a rapidly growing transcatheter heart valve replacement market.
Strong clinical need for
transcatheter solutions for TR
High market potential that is
Strong and highly motivated team
Strong IP protection
Unique design for safe, easy and